Correlation Between Bridgebio Pharma and Moderna

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bridgebio Pharma and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bridgebio Pharma and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bridgebio Pharma and Moderna, you can compare the effects of market volatilities on Bridgebio Pharma and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bridgebio Pharma with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bridgebio Pharma and Moderna.

Diversification Opportunities for Bridgebio Pharma and Moderna

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Bridgebio and Moderna is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Bridgebio Pharma and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and Bridgebio Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bridgebio Pharma are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of Bridgebio Pharma i.e., Bridgebio Pharma and Moderna go up and down completely randomly.

Pair Corralation between Bridgebio Pharma and Moderna

Given the investment horizon of 90 days Bridgebio Pharma is expected to generate 1.66 times more return on investment than Moderna. However, Bridgebio Pharma is 1.66 times more volatile than Moderna. It trades about 0.24 of its potential returns per unit of risk. Moderna is currently generating about 0.12 per unit of risk. If you would invest  722.00  in Bridgebio Pharma on April 4, 2022 and sell it today you would earn a total of  270.00  from holding Bridgebio Pharma or generate 37.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Bridgebio Pharma  vs.  Moderna

 Performance (%) 
      Timeline 
Bridgebio Pharma 
Bridgebio Performance
0 of 100
Over the last 90 days Bridgebio Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward indicators, Bridgebio Pharma is not utilizing all of its potentials. The new stock price mess, may contribute to short-term losses for the institutional investors.

Bridgebio Price Channel

Moderna 
Moderna Performance
0 of 100
Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest sluggish performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Moderna Price Channel

Bridgebio Pharma and Moderna Volatility Contrast

 Predicted Return Density 
      Returns 

Pair Trading with Bridgebio Pharma and Moderna

The main advantage of trading using opposite Bridgebio Pharma and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bridgebio Pharma position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.

Bridgebio Pharma

Pair trading matchups for Bridgebio Pharma

The idea behind Bridgebio Pharma and Moderna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Moderna

Pair trading matchups for Moderna

Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go